6534 logo

CH Biotech R&D Co., Ltd. Stock Price

TWSE:6534 Community·NT$9.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

6534 Share Price Performance

NT$0
-106.50 (-100.00%)
NT$0
-106.50 (-100.00%)
Price NT$0

6534 Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Outstanding track record with flawless balance sheet and pays a dividend.

1 Risk
2 Rewards

CH Biotech R&D Co., Ltd. Key Details

NT$1.9b

Revenue

NT$297.2m

Cost of Revenue

NT$1.6b

Gross Profit

NT$972.1m

Other Expenses

NT$604.7m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
6.00
84.14%
32.27%
27.1%
View Full Analysis

About 6534

Founded
2013
Employees
n/a
CEO
Wen Ren Chen
WebsiteView website
www.chbio.com

CH Biotech R&D Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of agriculture chemicals in Taiwan, the United States, and internationally. It offers fertilizers, biostimulants, and plant growth regulators; and provides biotechnology services. The company was incorporated in 2013 and is headquartered in Nantou City, Taiwan.

Recent 6534 News & Updates

Recent updates

No updates